Evidence that α2-Adrenergic pathways play a major role in growth hormone (GH) neuroregulation: α2-Adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH Response to GH-Releasing Hormone, while α2-Adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men

Journal of Clinical Endocrinology and Metabolism

Volumn 73, Issue 2, 1991, Pages 251-256

  Devesa, Jesus ^a   Diaz, Maria J ^a   Tresguerres, Jesus A F ^b   Arce, Victor ^a   Lima, Luis ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; ATROPINE; CLONIDINE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PYRIDOSTIGMINE; YOHIMBINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ATROPINE; CLONIDINE; FEMALE; GROWTH HORMONE; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; KINETICS; MALE; PYRIDOSTIGMINE BROMIDE; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, MUSCARINIC; SOMATOSTATIN; SOMATOTROPIN-RELEASING HORMONE; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; YOHIMBINE;

EID: 0025949955     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-73-2-251     Document Type: Article

References (29)

1. Taylor BJ, Smith PJ, Brook CGD. Inhibition of physiological growth hormone secretion by atropine. Clin Endocrinol (Oxf). 1985;22:497-501.
2. Mendelson WB, Sitaram N, Wyatt RJ. Methscopolamine inhibition of sleep-related growth hormone secretion. J Clin Invest. 1978;61:1683-90.
3. Peters RJ, Evans PJ, Page MD, et al. Cholinergic muscarinic receptor blockade with pirenzepine abolish slow wave sleep-related growth hormone release in normal adult males. Clin Endocrinol (Oxf). 1986;25:213-8.
4. Delitala G, Maoili M, Pacifico A, Brianda SA, Palermo M, Mannelli M. Cholinergic receptor control mechanism for L-dopa, apomor-phine and clonidine-induced growth hormone secretion in man. J Clin Endocrinol Metab. 1983;57:1145-9.
5. Casanueva FF, Villanueva L, Cabranes JA, Cabezas-Cerrato J, Fernândez-Cruz A. Cholinergic mediation of GH secretion elicited by arginine, clonidine and physical exercise in man. J Clin Endocrinol Metab. 1984;59:526-30.
6. Massara F, Ghigo E, Golfi S, Molinatti MG, Müller EE, Camanni F. Blockade of hp-GRF-40 induced GH release in normal men by a cholinergic muscarinic antagonist. J Clin Endocrinol Metab. 1984;59:1025-6.
7. Jordan V, Diéguez C, Lafaffian I, et al. Influence of dopaminergic, adrenergic and cholinergic blockade and TRH administration on GH responses to GRF 1-29. Clin Endocrinol (Oxf). 1986;24:291-8.
8. Casanueva FF, Villanueva L, Diéguez C, et al. Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level. J Clin Endocrinol Metab. 1986;62:186-91.
9. Casanueva FF, Villanueva L, Diaz Y, Devesa J, Fernandez-Cruz A, Schally AV. Atropine selectively blocks GHRH-induced GH secretion without altering LH, FSH, TSH, PRL and ACTH/cortisol secretion elicited by their specific hypothalamic releasing factors. Clin Endocrinol (Oxf). 1986;25:319-23.
10. Tamai H, Komaki G, Matsubayashi S, et al. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(l-44)-induced GH secretion in anorexia nervosa. J Clin Endocrinol Metab. 1990;70:738-41.
11. Massara F, Ghigo E, Demislis K, et al. Cholinergic involvement in the growth hormone-induced growth hormone release: studies in normal and acromegalic subjects. Neuroendocrinology. 1986;43:670-5.
12. Delitala G, Palermo H, Ross R, Coy D, Besser M, Grossman A. Dopaminergic and cholinergic influences on the growth hormone response to growth hormone-releasing hormone in man. Neuroendocrinology. 1987;45:243-6.
13. Massara F, Ghigo E, Molinatti P, et al. Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone releasing factor in man. Acta Endocrinol (Co-penh). 1986;113:12-6.
14. Locatelli V, Torsello A, Redaelli M, Ghigo E, Massara F, Müller EE. Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone releasing hormone in the rat: evidence for mediation by somatostatin. J Endocrinol. 1986;111:271-8.
15. Reiter EO, Morris AH, Biggs DE. Modulation of GHRH-induced growth hormone release by an alpha-adrenergic agonist and hypoglycemia. J Pediatr Endocrinol. 1988;3:21-5.
16. Devesa J, Arce V, Lois N, Tresguerres JAF, Lima L. a2-adrenergic agonism enhances the growth hormone response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men. J Clin Endocrinol Metab. 1990;71:1581-8.
17. Devesa J, Lima L, Lois N, et al. Reasons for the variability in growth hormone (GH) responses to GHRH challenge: the endogenous hypothalamic somatotroph rhythm. Clin Endocrinol (Oxf). 1989;30:367-77.
18. Lai S, Tolis G, Martin JB, Brown GM, Guyda H. Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone and thyroid-stimulating hormone in the serum of normal men. J Clin Endocrinol Metab. 1975;41:703-8.
19. Gil-Ad I, Tropper E, Laron Z. Oral clonidine as a growth hormone stimulation test. Lancet. 1979;2:278-80.
20. Miki N, Ono M, Shizume K. Evidence that opiatergic and alpha-adrenergic mechanisms stimulate rat growth hormone release via growth hormone-releasing factor. Endocrinology. 1984;114:1950-2.
21. Krulich L, Mayfield MA, Steele MK, McMillen BA, McCann SM, Koenig JL. Differential effects of pharmacological manipulations of central al and a2-adrenergic receptors on the secretion of thyrotropin and growth hormone in male rats. Endocrinology. 1982;110:796-804.
22. Minamitani N, Chihara K, Kaji H, Kodama H, Kita T, Fujita T. Alpha-2-adrenergic control of growth hormone secretion in conscious male rabbits: involvement of endogenous GH-releasing factor and somatostatin. Endocrinology. 1989;25:2839-45.
23. Celia SG, Locatelli V, De Gennaro V, Bondiolotti GP, Pintor C, Loche S, Provezza M, Müller EE. Epinephrine mediates the growth hormone-releasing effect of galanine in infant rats. Endocrinology. 1988;122:855-9.
24. Chatterjee VKK, Ball JA, Davis TME, Proby C, Burrin JM, Bloom SR. The effect of cholinergic blockade on the growth hormone response to galanin in humans. Metabolism. 1988;37:1089-91.
25. Tatar P, Vigas M. Role of alpha-1 and alpha-2 adrenergic receptors in the growth hormone and prolactin response to insulin-induced hypoglycemia in man. Neuroendocrinology. 1984;39:275-80.
26. Celia SG, Locatelli V, De Gennaro V, Pellini C, Pintor C, Müller EE. In vivo studies with growth hormone-releasing factor and clonidine in rat pups: ontogénie development of their effects on GH release and synthesis. Endocrinology. 1986;119:1164-70.
27. Owen JA, Nakatsu SL, Fenemore J, Condra M, Surridge DHC, Morales A. The pharmacokinetics of yohimbine in man. Eur J Clin Pharmacol. 1987;32:577-82.
28. Alba Roth J, Losa M, Spiess Y, Schopohl J, Muller OA, Von Werder K. Interaction of clonidine and GHRH on GH secretion in vivo and in vitro. Clin Endocrinol (Oxf). 1989;30:485-90.
29. Wetsfall TC. Local regulation of adrenergic neurotransmission. Physiol Rev. 1977;57:659-728.